lilly pharmacy tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly to sell Zepbound

Start your journey to better weight management today

Symptomatic post-bariatric hypoglycemia (#PBH) affects ~8% of people who have undergone bariatric surgery

While many on the medications said they have changed their lives for the better, some experts are concerned about the long-term effects of these relatively new drugs. Once its approved on the market, theyll collect data for like, a year, and thats it, said Alexis Moore, assistant professor of Physician Assistant studies and a clinician by training

Understanding their differences helps you make an informed choice with your provider

More tirzepatide users hit 10%, 15%, 20%, and 25% weight loss targets